Foventa Therapeutics Limited
- Company number
- 08803638
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 5 Dec 2013
- Nature of business
- Manufacture of basic pharmaceutical products
Registered office
Previous names
- Exonate Limited (until 21 Aug 2026)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| VENNING, Bruce Martyn, Dr | Secretary | 5 Dec 2013 | 15 Apr 2014 |
| IP2IPO SERVICES LIMITED | Corporate-Director | 10 Jun 2014 | 16 Oct 2015 |
| HILL, Adrian, Dr | Director | 17 Jul 2014 | 4 May 2016 |
| BATES, David Owen, Professor | Director | 5 Dec 2013 | 22 Jul 2021 |
| NAYLOR, Andrew James | Director | 27 Feb 2017 | 7 Nov 2022 |
| HARPER, Steven James, Professor | Director | 10 Jun 2014 | 13 Feb 2026 |
| FAZELI, Mohammad Sohail | Director | 8 Nov 2018 | 18 Jun 2026 |
| HELLEBO, Olav | Director | 18 Jun 2026 | |
| BATES, Phil | Director | 5 Mar 2026 | |
| HASAN, Rafiq, Dr | Director | 13 May 2024 | |
| KUREK, John | Director | 18 Nov 2016 | |
| TORRANCE, Christopher John, Dr | Director | 28 Sep 2015 | |
| SHAH, Sunil Rajen | Director | 10 Jun 2014 | |
| MINSHULL-BEECH, Catherine Susan, Dr | Director | 30 Jan 2014 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2024 | -£5,609,374 | £1,108,416 | 0 |
| 31 Dec 2023 | -£3,983,841 | £2,009,453 | 15 |
| 31 Dec 2022 | -£1,430,786 | £3,922,385 | 17 |
| 31 Dec 2021 | -£1,406,175 | £3,601,101 | 16 |
| 31 Dec 2020 | £1,431,540 | £3,787,945 | 15 |
| 31 Dec 2019 | -£180,026 | £761,196 | 14 |
| 31 Dec 2018 | -£1,827,299 | £1,951,853 | - |
| 31 Dec 2017 | - | - | - |
| 31 Dec 2016 | - | - | - |
| 31 Dec 2015 | - | - | - |
| 31 Dec 2014 | - | - | - |
Connections
Directors’ other companies
- SHAH, Sunil Rajen - Director at Bioindustry Association
- SHAH, Sunil Rajen - Director at TAY Therapeutics Limited
- SHAH, Sunil Rajen - Director at O2h Cowork Labs Limited